NK Cells Lose Their Inhibition

See allHide authors and affiliations

Science  06 Aug 2004:
Vol. 305, Issue 5685, pp. 786-787
DOI: 10.1126/science.1102025

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Hepatitis C virus (HCV) infects more than 180 million people worldwide and can lead to liver failure or liver cancer later in life. As Parham discusses in his thought-provoking Perspective, a step toward understanding how the human immune system resolves HCV infection and to developing a vaccine has been made with the finding that infected individuals of a particular genotype more readily resolve HCV infection than infected individuals of other genotypes ( Khakoo et al.).